Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Bone remodeling is a lifelong multi-cellular biological process in which mature bone tissue is removed by osteoclasts (bone resorption), followed by the formation of new bone tissue deposited by osteoblasts (ossification). This process plays essential roles in maintaining skeletal integrity, responding to mechanical stress, repairing microdamage, and regulating plasma calcium and phosphate concentrations. The remodeling cycle involves close coordination among bone cells—osteoclasts, osteoblasts, and osteocytes—within the so-called basic multicellular unit (BMU). Imbalances in bone remodeling activity contribute to diseases such as osteoporosis, osteoarthritis, and other metabolic bone disorders. Bone remodeling is regulated both systemically (e.g., parathyroid hormone, vitamin D, sex steroids) and locally (cytokines, growth factors), and therapeutic strategies often target the underlying cellular and molecular mechanisms to treat bone-related diseases.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Bone remodeling.